Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH

作者：Johannes Oldenburg, Robert Klamroth, Florian Länger, Manuela Albisetti, Charis von Auer, Cihan Ay, Wolfgang Korte, Rüdiger E. Scharf, Bernd Pötzsch, Andreas Greinacher · 发表于：Hämostaseologie · 年份：2021 · DOI：10.1055/a-1469-7481 · 被引用次数：259 · 研究领域：Heparin-Induced Thrombocytopenia and Thrombosis、Venous Thromboembolism Diagnosis and Management、Intramuscular injections and effects

The COVID-19 pandemic is an ongoing global healthcare crisis. Based on reports of atypically located thromboses following vaccination with the AstraZeneca COVID-19 vaccine, the Society of Thrombosis and Haemostasis Research (GTH) has issued guidance statements on the recognition, diagnosis, and treatment of this rare complication. It shares pathophysiological features with heparin-induced thrombocytopenia (HIT) and is referred to as vaccine-induced prothrombotic immune thrombocytopenia (VIPIT).